Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00155753
Status:
UNKNOWN
Last Update Posted:
2010-06-09
First Post:
2005-09-09
Brief Title:
Genomewide Screening of Pathological Myopia
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Genomewide Screening of Pathological Myopia
Status:
UNKNOWN
Status Verified Date:
2010-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the possible candidate gene of pathological myopia
Detailed Description:
High myopia pathological myopia is caused by excessive axial elongation that primarily involves the ora-equatorial area and the posterior pole Peripheral fundus changes and posterior staphyloma formation are ophthalmoscopic evidences of this process Pathological myopia often accompanied by glaucoma cataracts macular degeneration and retinal detachment leading to blindness when the damage to the retina is extremely severe Population and family studies in Chinese have provided evidence for a genetic component to pathologic myopia Children of myopic parents are more likely to have myopia than are children of nonmyopic parents The ocular components axial length anterior chamber depth and corneal curvature and refractive errors of MZ twins are more closely aligned than are those of DZ twins
Therefore it is possible to search a potential candidate gene for myopia through the genomic study of pathological myopia
Therefore it is possible to search a potential candidate gene for myopia through the genomic study of pathological myopia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None